Toxicogenomics – A Drug Development Perspective - Genomic Biomarkers for Pharmaceutical Development - page 148

[138] Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf
2007;6(6):673-84.
[139] Eun JW, et al. Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molec-
ular signatures of toxicants by expression proiling analysis. Toxicology 2008;249(2-3):176-83.
[140] Low Y, et al. Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches. Chem Res
Toxicol 2011;24(8):1251-62.
[141] Parman T, et al. Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxic-
ity. Toxicol Sci 2011;124(2):487-501.
[142] Zhao Q, et al. Epigenetic modiications in hepatic stellate cells contribute to liver ibrosis. Tohoku J Exp Med
2013;229(1):35-43.
[143] Xie GH, et al. Hedgehog signaling regulates liver sinusoidal endothelial cell capillarisation. Gut
2013;62(2):299-309.
[144] Loi P, et al. Interferon regulatory factor 3 deiciency leads to interleukin-17-mediated liver ischemia-reperfu-
sion injury. Hepatology 2013;57(1):351-61.
[145] Hawkins MT, Lewis JH. Latest advances in predicting DILI in human subjects: focus on biomarkers. Expert
Opin Drug Metab Toxicol 2012;8(12):1521-30.
[146] Zheng JL, et al. Assessment of subclinical, toxicant-induced hepatic gene expression proiles after low-dose,
short-term exposures in mice. Regul Toxicol Pharmacol 2011;60(1):54-72.
[147] Kiyosawa N, et al. Toxicogenomic biomarkers for liver toxicity. J Toxicol Pathol 2009;22(1):35-52.
[148] Yang X, Salminen W, et al. Current and emerging biomarkers of hepatotoxicity. Curr Biomarker Find
2012;2:43-55.
[149] Kuehn BM. FDA focuses on drugs and liver damage labeling and other changes for acetaminophen. JAMA
2009;302(4):369-71.
[150] Bushel PR, et al. Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci USA
2007;104(46):18211-16.
[151] Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology - with emphasis on cytochrome
P450. Toxicol Sci 2011;120(1):1-13.
[152] Przybylak KR, Cronin MTD. In silico models for drug-induced liver injury - current status. Expert Opin Drug
Metab Toxicol 2012;8(2):201-17.
[153] ICH Topic S4, duration of chronic toxicity testing in animals (rodent and non rodent toxicity testing), May 1999
CPMP/ICH?300/95.
[154] Arcangeli S, et al. Updated results and patterns of failure in a randomized hypofractionation trial for high-
risk prostate cancer. Int J Radiat Oncol Biol Phys 2012;84(5):1172-8.
[155] LeCluyse EL, et al. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev
Toxicol 2012;42(6):501-48.
[156] Landis GN, et al. Similar gene expression patterns characterize aging and oxidative stress in Drosophila mela-
nogaster . Proc Natl Acad Sci USA 2004;101(20):7663-8.
[157] Bol D, Ebner R. Gene expression proiling in the discovery, optimization and development of novel drugs:
one universal screening platform. Pharmacogenomics 2006;7(2):227-35.
[158] Holack JC, Roth AB, Suter L. Toxicogenomics: a predictive tool in toxicology and drug development. Drug
Metab Rev 2010;42:4.
[159] Nam SW. Expression toxicogenomics in predictive toxicology and risk assessment. Mol Cell Toxicol 2009;
5(3):45.
[160] Williams-Devane CR, Wolf MA, Richard AM. Toward a public toxicogenomics capability for support-
ing predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and
ArrayExpress. Toxicol Sci 2009;109(2):358-71.
[161] Vanhaecke T, et al. EU research activities in alternative testing strategies: current status and future perspec-
tives. Arch Toxicol 2009;83(12):1037-42.
[162] Yamamoto K, et al. Effect of globin digest on the liver injury and hepatic gene expression proile in galactosa-
mine-induced liver injury in SD rats. Life Sci 2011;88(15-16):701-12.
[163] Yang Q, et al. Dynamics of short-term gene expression proiling in liver following thermal injury. J Surg Res
2012;176(2):549-58.
[164] Suh SK, et al. Gene expression proiling of acetaminophen induced hepatotoxicity in mice. Mol Cell Toxicol
2006;2(4):236-43.